Drug intelligence / Profile preview

biejiajianwan

Development stage
Unknown
Lead developer
Sinopharm Wuhan ZhongLian SiYao Pharmaceutical
Administration
Oral
01

Overview

Biejiajianwan is a classic Traditional Chinese Medicine (TCM) formula, first recorded in the Han Dynasty text *Synopsis of Prescriptions of the Golden Chamber* (Jin Gui Yao Lue), primarily used for the treatment of abdominal masses and liver-related disorders. It is a complex multi-ingredient preparation traditionally composed of 23 components, with Carapax Trionycis (turtle shell) as the sovereign medicinal, alongside other ingredients such as Donkey-hide gelatin, Rheum palmatum, and Scutellaria baicalensis. The formula is indicated for "softening hardness and dissipating masses" (Ruan Jian San Jie), specifically targeting hepatic fibrosis, liver cirrhosis, and splenomegaly. Modern pharmacological studies suggest it works by inhibiting the TGF-beta1/Smad signaling pathway, reducing the activation of hepatic stellate cells, and promoting the degradation of the extracellular matrix. It is widely manufactured in China, notably by Sinopharm Group Zhonglian Pharmaceutical, and is frequently used as an adjunctive therapy for chronic hepatitis B-related fibrosis and cirrhosis.

Brand names
Biejiajian Wan
Other names
Biejiajian PillsBiejiajian Pill鳖甲煎丸
02

Targets

TGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on biejiajianwan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on biejiajianwan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call